Weekly Update: New diabetes clinical trial (18 items)

New diabetes clinical trial: Kidney Check: Diabetes, Blood Pressure & Kidney Health Checks & Care in Indigenous Communities. Published on: July 23, 2018 at 07:00PM Conditions:   Chronic Kidney Disease;   Diabetes;   Hypertension Intervention:   Other: Point-of-care screening Sponsors:   University of Manitoba;   Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease;   Alberta Health Services;   First Nations Health Authority;   First Nations Health and Social Secretariat of Manitoba;   Manitoba Renal Program Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03595267?term=diabetes&sfpd_d=14 July 23, 2018 at 04:27PM via ClinicalTrials.gov New diabetes clinical trial: A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Subjects With Type 2 Diabetes Mellitus Published on: July 23, 2018 at 07:00PM Conditions:   Diabetes Mellitus, Type II;   Obesity Interventions:   Drug: MEDI0382;   Drug: Placebo Sponsor:   MedImmune LLC Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03596177?term=diabetes&sfpd_d=14 July 23, 2018 at 04:27PM via ClinicalTrials.gov New diabetes clinical trial: Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial Published on: July 23, 2018 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Semaglutide;   Drug: Standard of care Sponsor:   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03596450?term=diabetes&sfpd_d=14 July 23, 2018 at 04:27PM via ClinicalTrials.gov New diabetes clinical trial: Soccer-based Adaptation of the Diabetes Prevention Program Published on: July 23, 2018 at 07:00PM Condition:   Diabetes Intervention:   Behavioral: Soccer-based adaptation to the DPP Sponsors:   Emory University;   Georgia Center for Diabetes Translation Research;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting https://clinicaltrials.gov/ct2/show/NCT03595384?term=diabetes&sfpd_d=14 July 23, 2018 at 04:27PM via ClinicalTrials.gov New diabetes clinical trial: Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-On Published on: July 24, 2018 at 07:00PM Conditions:   Type2 Diabetes;   Hyperkalemia Intervention:   Drug: Spironolactone Sponsors:   University Hospitals Cleveland Medical Center;   Relypsa, Inc. Recruiting https://clinicaltrials.gov/ct2/show/NCT03597035?term=diabetes&sfpd_d=14 July 24, 2018 at 11:19PM via ClinicalTrials.gov New diabetes clinical trial: Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM Published on: July 24, 2018 at 07:00PM Condition:   ASCVD, Type 2 DM Interventions:   Drug: Rosuvamibe;   Drug: Monorova Sponsor:   Yuhan Corporation Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03597412?term=diabetes&sfpd_d=14 July 24, 2018 at 11:19PM via ClinicalTrials.gov New diabetes clinical trial: Genetic Causes of Hypercholesterolaemia in the Emirati Population Published on: July 24, 2018 at 07:00PM Condition:   Familial Hypercholesterolemia Intervention:   Genetic: Next generation sequencing (NGS) Sponsor:   Imperial College London Diabetes Centre Recruiting https://clinicaltrials.gov/ct2/show/NCT03597958?term=diabetes&sfpd_d=14 July 24, 2018 at 11:19PM via ClinicalTrials.gov New diabetes clinical trial: Collection of Breath and Sweat to Identify Indicators of Hypoglycemia Published on: July 25, 2018 at 07:00PM Condition:   Type 1 Diabetes Mellitus Intervention:   Drug: Insulin Lispro Sponsors:   Massachusetts General Hospital;   Mitre Medical Corp. Recruiting https://clinicaltrials.gov/ct2/show/NCT03600116?term=diabetes&sfpd_d=14 July 26, 2018 at 06:52PM via ClinicalTrials.gov New diabetes clinical trial: Ischemic Preconditioning and Type 2 Diabetes Published on: July 25, 2018 at 07:00PM Condition:   Type 2 Diabetes Mellitus Intervention:   Other: Ischemic Preconditioning Sponsors:   Liverpool John Moores University;   Aintree University Hospitals NHS Foundation Trust Recruiting https://clinicaltrials.gov/ct2/show/NCT03598855?term=diabetes&sfpd_d=14 July 26, 2018 at 06:52PM via ClinicalTrials.gov New diabetes clinical trial: The Effect of Esomeprazole on Type 2 Diabetes Published on: July 25, 2018 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Intervention:   Drug: Esomeprazole 40mg Sponsor:   Baskent Univesity Ankara Hospital Completed https://clinicaltrials.gov/ct2/show/NCT03598738?term=diabetes&sfpd_d=14 July 26, 2018 at 06:52PM via ClinicalTrials.gov New diabetes clinical trial: HIT on Hypoglycemic Risk in Type 1 Diabetes (T1D) Published on: July 25, 2018 at 07:00PM Condition:   Type1diabetes Interventions:   Behavioral: high intensity interval training;   Behavioral: moderate intensity continous training Sponsors:   Liverpool John Moores University;   Society for Endocrinology;   Royal Liverpool University Hospital;   University of Birmingham;   University of Exeter Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03598400?term=diabetes&sfpd_d=14 July 26, 2018 at 06:52PM via ClinicalTrials.gov New diabetes clinical trial: Effectiveness of OHP in Improving Self-efficacy in Patients With Diabetes Mellitus Published on: July 26, 2018 at 07:00PM Conditions:   Diabetes Mellitus;   Chronic Illness Interventions:   Behavioral: Optimal Health Program;   Other: Treatment as Usual Sponsors:   Universiti Putra Malaysia;   St Vincent's Hospital Melbourne Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03601884?term=diabetes&sfpd_d=14 July 26, 2018 at 06:52PM via ClinicalTrials.gov New diabetes clinical trial: Comparison Between Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System and the FreeStyle Libre Flash Glucose Monitoring System Published on: July 27, 2018 at 07:00PM Condition:   Type 1 Diabetes Mellitus Intervention:   Device: Dexcom G5 Mobile CGM system Sponsor:   Jessa Hospital Recruiting https://clinicaltrials.gov/ct2/show/NCT03602963?term=diabetes&sfpd_d=14 July 27, 2018 at 04:52PM via ClinicalTrials.gov New diabetes clinical trial: Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Published on: July 27, 2018 at 07:00PM Condition:   Atherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1 Interventions:   Drug: Sitagliptin;   Drug: Acarbose Sponsor:   Chinese PLA General Hospital Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03602638?term=diabetes&sfpd_d=14 July 27, 2018 at 04:52PM via ClinicalTrials.gov New diabetes clinical trial: Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes Published on: July 27, 2018 at 07:00PM Condition:   Type 2 Diabetes Mellitus (T2DM) Interventions:   Drug: PB-119 100 μg+ Glucophage®;   Drug: PB-119 150 μg+ Glucophage®;   Drug: PB-119 200 μg+ Glucophage®;   Drug: PB-119 placebo + Glucophage® Sponsors:   PegBio Co., Ltd.;   Covance Recruiting https://clinicaltrials.gov/ct2/show/NCT03604419?term=diabetes&sfpd_d=14 July 27, 2018 at 04:52PM via ClinicalTrials.gov New diabetes clinical trial: A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Published on: July 27, 2018 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: LY3209590;   Drug: Placebo Sponsor:   Eli Lilly and Company Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03603704?term=diabetes&sfpd_d=14 July 27, 2018 at 04:52PM via ClinicalTrials.gov New diabetes clinical trial: Diabetes in Pregnancy and Pregnancy Outcomes Published on: July 27, 2018 at 07:00PM Conditions:   Diabetes Mellitus in Pregnancy;   Diabetes, Gestational Interventions:   Dietary Supplement: Medical Nutrition Therapy;   Drug: Insulin;   Drug: Oral Antidiabetics Sponsors:   Faculty of Medicine, Tarumanagara University;   Hermina Podomoro Hospital Completed https://clinicaltrials.gov/ct2/show/NCT03602846?term=diabetes&sfpd_d=14 July 27, 2018 at 04:52PM via ClinicalTrials.gov New diabetes clinical trial: An Observational Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting Published on: July 27, 2018 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Intervention:   Drug: Canagliflozin 300 mg Sponsor:   Johnson & Johnson Private Limited Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT03604224?term=diabetes&sfpd_d=14 July 27, 2018 at 04:52PM via ClinicalTrials.gov